On August 12, 2025, U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a sweeping policy to prohibit federal funding, including Medicaid and Medicare, to hospitals and institutions performing transgender surgeries on minors. The directive, aligning with President Trump’s executive order recognizing only two sexes, marks a significant rollback of Biden-era transgender health protections. Kennedy called such procedures “mutilation surgeries,” arguing they lack sufficient scientific backing and harm vulnerable youth.
The policy targets gender-affirming care, including surgeries and hormone therapies, for those under 18, following a 400-page HHS report from May 1, 2025, questioning the efficacy and safety of these interventions. Facilities receiving federal funds must cease such procedures or risk losing support, impacting major hospitals nationwide. Kennedy emphasized protecting children, citing restrictions on other age-limited activities like drinking or driving.
Critics, including the American Academy of Pediatrics, condemned the move as discriminatory, arguing it denies evidence-based care and exacerbates mental health risks for transgender youth. Legal challenges are expected, with groups like the ACLU vowing to fight the ban, citing violations of equal protection. Supporters, however, praise the policy as safeguarding minors from irreversible decisions, aligning with states like Montana that have restricted similar practices.
The announcement follows Kennedy’s broader HHS reforms, including slashing $500 million in mRNA vaccine funding, reflecting his skepticism of certain medical interventions. As the policy takes effect, it could reshape healthcare access and fuel national debates over transgender rights and medical ethics.
